Company intelligence / Profile preview
Monyan
San Francisco, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Monyan is an early-stage biotechnology company focused on the field of longevity and cellular rejuvenation. The company leverages advanced epigenetic reprogramming technologies to reverse cellular aging and restore youthful function to tissues. By targeting the fundamental drivers of biological aging, Monyan aims to develop therapeutics that can treat a wide range of age-related chronic diseases. The company operates primarily in stealth mode, focusing on foundational research and platform development to identify novel targets for rejuvenation.
- Therapeutic areas
- Other
- Modalities
- Small moleculeGene therapyBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Monyan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Monyan.